hims, inc. manufactures men's wellness products. it offers products, including hair loss prevention medicines, sexual wellness products, skincare products, and oral care products. the company also provides sweaters, jackets, corduroy, sport coats, wool overcoat, leather boots, flannel, shirts, caps, and candles. it sells its products online. the company was incorporated in 2013 and is based in san francisco, california.
Company profile
Ticker
HIMS
Exchange
Website
CEO
Andrew Dudum
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Oaktree Acquisition Corp.
SEC CIK
Corporate docs
Subsidiaries
Hims, Inc. • H&H Derm, LLC • H&H Healthcare Management, Inc. • H&H Pharmacy Management, Inc. • Hims & Hers UK Limited ...
HIMS stock data
Latest filings (excl ownership)
8-K
Departure of Directors or Certain Officers
3 Apr 24
S-8
Registration of securities for employees
26 Feb 24
10-K
2023 FY
Annual report
26 Feb 24
8-K
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
26 Feb 24
10-Q
2023 Q3
Quarterly report
6 Nov 23
8-K
Hims & Hers Health, Inc. Reports Third Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
6 Nov 23
10-Q
2023 Q2
Quarterly report
7 Aug 23
8-K
Hims & Hers Health, Inc. Reports Second Quarter 2023 Financial Results and Raises Full Year 2023 Outlook
7 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
10-Q
2023 Q1
Quarterly report
8 May 23
Transcripts
HIMS
Earnings call transcript
2023 Q3
6 Nov 23
HIMS
Earnings call transcript
2023 Q2
7 Aug 23
HIMS
Earnings call transcript
2023 Q1
8 May 23
HIMS
Earnings call transcript
2022 Q4
27 Feb 23
HIMS
Earnings call transcript
2022 Q3
8 Nov 22
HIMS
Earnings call transcript
2022 Q2
9 Aug 22
HIMS
Earnings call transcript
2022 Q1
10 May 22
HIMS
Earnings call transcript
2021 Q4
23 Feb 22
HIMS
Earnings call transcript
2021 Q3
11 Nov 21
HIMS
Earnings call transcript
2021 Q2
12 Aug 21
Latest ownership filings
4
Soleil Boughton
16 Apr 24
144
Notice of proposed sale of securities
15 Apr 24
4
Melissa Baird
8 Apr 24
4
Andrew Dudum
8 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
144
Notice of proposed sale of securities
5 Apr 24
3
Christopher D Payne
4 Apr 24
144
Notice of proposed sale of securities
4 Apr 24
4
Soleil Boughton
2 Apr 24
144
Notice of proposed sale of securities
1 Apr 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm | 58.85 mm |
Cash burn (monthly) | 2.47 mm | (no burn) | 2.85 mm | 3.39 mm | (no burn) | (no burn) |
Cash used (since last report) | 16.82 mm | n/a | 19.39 mm | 23.03 mm | n/a | n/a |
Cash remaining | 42.03 mm | n/a | 39.47 mm | 35.82 mm | n/a | n/a |
Runway (months of cash) | 17.0 | n/a | 13.8 | 10.6 | n/a | n/a |
Institutional ownership, Q3 2023
77.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 196 |
Opened positions | 33 |
Closed positions | 31 |
Increased positions | 72 |
Reduced positions | 54 |
13F shares | Current |
---|---|
Total value | 701.80 bn |
Total shares | 159.29 mm |
Total puts | 1.85 mm |
Total calls | 1.41 mm |
Total put/call ratio | 1.3 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 14.13 mm | $88.86 bn |
BLK Blackrock | 10.35 mm | $65.07 bn |
Forerunner Partners III | 9.76 mm | $0.00 |
NewView HMS SPV | 9.70 mm | $0.00 |
NewView Capital Fund I | 9.66 mm | $0.00 |
Institutional Venture Management XVI | 7.72 mm | $48.57 bn |
Institutional Venture Management XV | 7.72 mm | $48.57 bn |
Redpoint Management | 7.58 mm | $47.66 bn |
Redpoint Ventures VI | 7.58 mm | $78.42 mm |
Oaktree Acquisition | 6.79 mm | $0.00 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | Soleil Boughton | Class A Common Stock | Sell | Dispose S | No | Yes | 13.95 | 2,503 | 34.92 k | 164,363 |
8 Apr 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 14.7439 | 6,715 | 99.01 k | 538,932 |
8 Apr 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 14.7436 | 5,036 | 74.25 k | 545,647 |
8 Apr 24 | Melissa Baird | Class A Common Stock | Option exercise | Acquire M | No | Yes | 0.4 | 11,751 | 4.70 k | 550,683 |
8 Apr 24 | Melissa Baird | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 0.4 | 11,751 | 4.70 k | 740,158 |
5 Apr 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 14.5825 | 6,715 | 97.92 k | 538,932 |
5 Apr 24 | Melissa Baird | Class A Common Stock | Sell | Dispose S | No | Yes | 14.5851 | 5,036 | 73.45 k | 545,647 |
5 Apr 24 | Melissa Baird | Class A Common Stock | Option exercise | Acquire M | No | Yes | 0.4 | 11,751 | 4.70 k | 550,683 |
5 Apr 24 | Melissa Baird | Stock Option Class A Common Stock | Option exercise | Dispose M | No | Yes | 0.4 | 11,751 | 4.70 k | 751,909 |
4 Apr 24 | Andrew Dudum | Class A Common Stock | Sell | Dispose S | Yes | Yes | 15.3852 | 15,898 | 244.59 k | 1,454,866 |
News
Jefferies Downgrades Hims & Hers Health to Hold, Lowers Price Target to $15
16 Apr 24
Breaking Down Hims & Hers Health: 6 Analysts Share Their Views
10 Apr 24
Canaccord Genuity Initiates Coverage On Hims & Hers Health with Buy Rating, Announces Price Target of $20
10 Apr 24
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday
4 Apr 24
A Closer Look at Hims & Hers Health's Options Market Dynamics
4 Apr 24
Press releases
Hims & Hers to Announce First Quarter 2024 Financial Results on May 6, 2024
15 Apr 24
Hims & Hers Appoints Christopher Payne, Seasoned Tech Industry Executive, as Newest Board Member
3 Apr 24
Hims & Hers to Participate in Canaccord Genuity's Virtual eCommerce Sustainable Advantage Forum on March 14, 2024
11 Mar 24
Thinking about buying stock in Infobird, PubMatic, Hims & Hers Health, FibroGen, or Alpha Metallurgical Resources?
27 Feb 24
Hims & Hers to Announce Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024
5 Feb 24